Research & Development

ACI has recently developed Nevirax, which is the generic version of Pfizer Inc’s Paxlovid^TM

ACI has recently developed Nevirax, which is the generic version of Pfizer Inc’s Paxlovid^TM.  Paxlovid^TM is an orally administered Covid-19 antiviral authorized for emergency use by the U.S. Food and Drug Administration (USFDA) in both high-risk adults and high-risk pediatric patients 12 years of age and older.

2 Strips Combipack
Each strip contains:
2 film coated tablets of Nirmatrelvir INN 150 mg &
1 film coated tablet of Ritonavir USP 100 mg